ACTU ACTUATE THERAPEUTICS, INC.
Pharmaceutical Preparations · Nasdaq · SEC CIK 1652935 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY23.4%
TTM EPS YoY-323.5%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE-364.7%
ROA-176.4%
ROIC (approx.)—
Asset turnover—
Leverage & solvency
Liabilities / assets125.1%
Debt / equity—
Current ratio0.73x
Interest coverage-925.44x
Cash quality & payout
Operating cash flow / net income0.87x
Accruals ratio-22.5%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 |
|---|---|---|---|
| Income statement | |||
| Revenue | — | — | — |
| R&D expense | $10.29M | $18.68M | $21.71M |
| SG&A expense | $12.20M | $6.48M | $3.27M |
| Operating income | -$22.50M | -$25.16M | -$24.97M |
| Interest expense | $20,250 | $18,717 | $43,641 |
| Income tax | $800 | $800 | $0 |
| Net income | -$22.23M | -$27.29M | -$24.74M |
| EPS (basic) | -1.06 | -3.26 | -17.24 |
| EPS (diluted) | -1.06 | -3.26 | -17.24 |
| Weighted avg. shares (diluted) | 21.02M | 8.37M | 1.43M |
| Balance sheet | |||
| Cash & equivalents | $13.16M | $8.64M | $2.96M |
| Current assets | $13.64M | $9.21M | $3.00M |
| Total assets | $14.04M | $9.32M | $3.00M |
| Current liabilities | $5.71M | $8.80M | $6.92M |
| Total liabilities | $6.11M | $9.21M | $8.44M |
| Shareholders' equity | $7.92M | $104,186 | -$99.63M |
| Shares outstanding | 23.25M | 19.53M | 1.69M |
| Cash flow statement | |||
| Operating cash flow | -$19.21M | -$21.84M | -$21.63M |
| Financing cash flow | $23.72M | $27.53M | $4.13M |
| Stock-based compensation | $6.05M | $2.00M | $423,539 |
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.